Page last updated: 2024-11-13

macranthoidin b

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators
FloraRankFlora DefinitionFamilyFamily Definition
LoniceragenusA plant genus of the family CAPRIFOLIACEAE. Members contain iridoid glucosides.[MeSH]CaprifoliaceaeA plant family of the order Dipsacales, subclass Asteridae, class Magnoliopsida.[MeSH]

Cross-References

ID SourceID
PubMed CID71307567
MeSH IDM0222077

Synonyms (20)

Synonym
macranthoidin b ,
unii-9s74s1aghc
3-o-beta-d-glucopyranosyl-(1-4)-beta-d-glucopyranosyl-(1-3)-alpha-l-rhamnopyranosyl-(1-2)-alpha-l-arabinopyranosyl-3,23-dihydroxyolean-12-en-28-o-d-glucopyranosyl-(1-6)glucopyranoside
136849-88-2
olean-12-en-28-oic acid, 3-((o-beta-d-glucopyranosyl-(1-4)-o-beta-d-glucopyranosyl-(1-3)-o-6-deoxy-alpha-l-mannopyranosyl-(1-2)-alpha-l-arabinopyranosyl)oxy)-23-hydroxy, 6-o-beta-d-glucopyranosyl-beta-d-glucopyranosyl ester, (3beta,4alpha)-
9s74s1aghc ,
olean-12-en-28-oic acid, 3-((o-beta-d-glucopyranosyl-(1-4)-o-beta-d-glucopyranosyl-(1-3)-o-6-deoxy-alpha-l-mannopyranosyl-(1-2)-alpha-l-arabinopyranosyl)oxy)-23-hydroxy-, 6-o-beta-d-glucopyranosyl-beta-d-glucopyranosyl est
S3916
CS-3911
AC-33964
HY-N0864
3-((o-.beta.-d-glucopyranosyl-(1->4)-o-.beta.-d-glucopyranosyl-(1->3)-o-6-deoxy-.alpha.-l-mannopyranosyl-(1->2)-.alpha.-l-arabinopyranosyl)oxy)-23-hydroxy-olean-12-en-28-oic acid 6-o-.beta.-d-glucopyranosyl-.beta.-d-glucopyranosyl ester, (3.beta.,4.alpha.
macranthoidinb
mfcd20487834
AKOS037514731
AS-75343
macranthoiside i
olean-12-en-28-oic acid, 3-[(o-beta-d-glucopyranosyl-(1-->4)-o-beta-d-glucopyranosyl-(1-->3)-o-6-deoxy-alpha-l-mannopyranosyl-(1-->2)-alpha-l-arabinopyranosyl)oxy]-23-hydroxy-, 6-o-beta-d-glucopyranosyl-beta-d-glucopyranosyl ester, (3beta,4alpha)-
CCG-270678
Q27273041

Research Excerpts

Overview

Macranthoidin B (MB) is a potent inducer of ROS-mediated apoptosis in cancer. Its mechanism of action is poorly understood.

ExcerptReferenceRelevance
"Macranthoidin B (MB) is a potent inducer of ROS-mediated apoptosis in cancer, but its mechanism of action is poorly understood."( Macranthoidin B Modulates Key Metabolic Pathways to Enhance ROS Generation and Induce Cytotoxicity and Apoptosis in Colorectal Cancer.
Cui, W; Fan, X; Li, D; Rao, J; Shen, Q; Tou, F; Wang, H; Zhang, J; Zhang, Z; Zheng, Z, 2018
)
2.64

Pharmacokinetics

ExcerptReferenceRelevance
" This developed method was subsequently successfully applied to pharmacokinetic profiles of the four saponins in rats."( Liquid chromatography-mass spectrometry analysis of macranthoidin B, macranthoidin A, dipsacoside B, and macranthoside B in rat plasma for the pharmacokinetic investigation.
Chen, CY; Li, P; Qi, LW; Wen, XD; Yi, L, 2009
)
0.6
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (12.50)18.2507
2000's1 (12.50)29.6817
2010's5 (62.50)24.3611
2020's1 (12.50)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 18.23

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index18.23 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index5.24 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (18.23)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]